CYSB2400248 | 注射用人干扰素γ | Human Interferon γ | Lyophilized | Biological Products | Supplementary Application | 2024-09-19 | | Shanghai Chemo Wanbang Biophama Co Ltd | | | view |
CXSS2100026 | 注射用人干扰素γ | Human Interferon γ | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-02 | 上海凯茂生物医药有限公司 | Shanghai Chemo Wanbang Biophama Co Ltd | In Review | 2021-03-01 | view |
CXSS2100029 | 注射用人干扰素γ | Human Interferon γ | Lyophilized | Biological Products(3.2) | New Drug Application | 2021-03-02 | 上海凯茂生物医药有限公司 | Shanghai Chemo Wanbang Biophama Co Ltd | In Review | 2021-03-01 | view |
CXSS2100028 | 注射用人干扰素γ | Human Interferon γ | Lyophilized | Biological Products(3.2) | New Drug Application | 2021-03-02 | 上海凯茂生物医药有限公司 | Shanghai Chemo Wanbang Biophama Co Ltd | In Review | 2021-03-01 | view |
CXSS2100027 | 注射用人干扰素γ | Human Interferon γ | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-02 | 上海凯茂生物医药有限公司 | Shanghai Chemo Wanbang Biophama Co Ltd | In Review | 2021-03-01 | view |